Insufficient
drug delivery into
tumor cells limits the therapeutic efficacy of
chemotherapy. Co-delivery of
liposome-encapsulated
drug and synthetic short-chain
glycosphingolipids (SC-GSLs) significantly improved
drug bioavailability by enhancing intracellular
drug uptake. Investigating the mechanisms underlying this SC-GSL-mediated
drug uptake enhancement is the aim of this study. Fluorescence microscopy was used to visualize the
cell membrane lipid transfer intracellular fate of fluorescently labeled C6-NBD-GalCer incorporated in
liposomes in
tumor and non-
tumor cells. Additionally click chemistry was applied to image and quantify native SC-GSLs in
tumor and non-
tumor cell membranes. SC-GSL-mediated flip-flop was investigated in model membranes to confirm membrane-incorporation of SC-GSL and its effect on membrane remodeling. SC-GSL enriched
liposomes containing
doxorubicin (Dox) were incubated at 4°C and 37°C and intracellular
drug uptake was studied in comparison to standard
liposomes and free Dox. SC-GSL transfer to the cell membrane was independent of liposomal uptake and the majority of the transferred
lipid remained in the plasma membrane. The transfer of SC-GSL was
tumor cell-specific and induced membrane rearrangement as evidenced by a transbilayer flip-flop of
pyrene-SM. However, pore formation was measured, as leakage of hydrophilic
fluorescent probes was not observed. Moreover,
drug uptake appeared to be mediated by SC-GSLs. SC-GSLs enhanced the interaction of
doxorubicin (Dox) with the outer leaflet of the plasma membrane of
tumor cells at 4°C. Our results demonstrate that SC-GSLs preferentially insert into
tumor cell plasma membranes enhancing cell intrinsic capacity to translocate amphiphilic drugs such as Dox across the membrane via a biophysical process.